Clinical Trial Update: WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults

View source ↗

Summary

A completed real-world evidence study evaluated personalized dosing of semaglutide in U.S. adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Closed Loop Medicine | Conditions: Obesity & Overweight | Status: COMPLETED